Piperazine derivatives for treating disorders

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9796707
SERIAL NO

15609596

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Anti-angiogenic treatments, treatments of hyperpermeability disorders, treatments of neuropathic and neurodegenerative disorders, pain treatments, methods of reducing the risk of pre-eclampsia and compounds for use in such methods are described.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
EXONATE LIMITEDMOORFIELD ROAD DUXFORD CAMBRIDGE CB22 4PS

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bates, David Nottinghamshire, GB 30 143
Morris, Jonathan New South Wales, AU 49 1870

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 24, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 24, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00